Saturday, September 02, 2017 12:05:53 PM
2017-08-16 06:18 ET - News Release
PREVECEUTICAL MEDICAL BEGINS TRADING ON THE OTC MARKET
Preveceutical Medical Inc. is quoting its common shares for trading on the OTC Pink market, under the symbol PRVCF.
In connection with the quotation of its shares on the OTC, the company is completing its filings for the quotation of its shares on the OTCQB market. The company has also made an application for its common shares to be DTC eligible and expects to receive this designation within the next 30 days.
Preveceutical's chairman and chief executive officer, Stephen Van Deventer, commented, "An OTC quotation will provide further liquidity for both existing and new shareholders and increase Preveceutical's presence in the United States."
Recent PRVCF News
- Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program • AllPennyStocks.com • 12/04/2023 01:00:00 PM
- Dual Listed Biotech Begins to Prepare POC Preclinical Study for Diabetes & Obesity Dual Gene Therapy Program • AllPennyStocks.com • 12/04/2023 01:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM